Debanjana Chatterjee
Stock Analyst at Jones Trading
(n/a)
# 4,373
Out of 4,735 analysts
4
Total ratings
n/a
Success rate
-34.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Debanjana Chatterjee
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
SYRE Spyre Therapeutics | Initiates: Hold | n/a | $22.28 | - | 1 | Dec 11, 2024 | |
KALV KalVista Pharmaceuticals | Initiates: Buy | $35 | $8.75 | +300.00% | 1 | Sep 27, 2024 | |
PHVS Pharvaris | Initiates: Buy | $46 | $19.12 | +140.59% | 1 | Sep 19, 2024 | |
NTLA Intellia Therapeutics | Initiates: Buy | $41 | $9.94 | +312.47% | 1 | Sep 17, 2024 |
Spyre Therapeutics
Dec 11, 2024
Initiates: Hold
Price Target: n/a
Current: $22.28
Upside: -
KalVista Pharmaceuticals
Sep 27, 2024
Initiates: Buy
Price Target: $35
Current: $8.75
Upside: +300.00%
Pharvaris
Sep 19, 2024
Initiates: Buy
Price Target: $46
Current: $19.12
Upside: +140.59%
Intellia Therapeutics
Sep 17, 2024
Initiates: Buy
Price Target: $41
Current: $9.94
Upside: +312.47%